Toggle navigation
Home
Search
Services
Blog
Contact
About
Treatment of Preserved Systolic Function with an Aldosterone Antagonist
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Receptor Mimics for Rapid Detection, Typing, and Susceptibility Testing of Influe
The role of CD36 in ischemic inflammation and injury
Roll Your Own (RYO) Cigarettes: Prevalence, Smoking Behavior and Toxin Exposure
Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study
Meiotic spindle formation in Drosophila females
Recently added grants:
Plasma Cell-Free RNA as Non-invasive Biomarker for Neurodegeneration
Impact of T cells on age-related vascular dysfunction: A translational approach
Vitamin B12 status, cognitive decline and incident dementia
Metabolomics of Neurocognitive Risk for Dementia in Diabetes
Inhibitors targeting ribosome interactions of ricin
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HC45207-10-0-1
Application #
7569624
Study Section
Project Start
2004-08-01
Project End
2012-07-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Treatment of Preserved Systolic Function with an Aldosterone Antagonist
/ New England Research Institute
$7,912,414
NIH 2007
N01 HL
Aldosterone Antagonists for the Treatment of Heart Failure with Preserved Systol
McKinlay, Sonja M. /
$2,217,724
NIH 2007
N01 HL
Treatment of Preserved Systolic Function with an Aldosterone Antagonist
/
NIH 2007
N01 HL
/
Comments
Be the first to comment on this grant
